Successful treatment of Henoch-Schonlein purpura nephritis with plasma exchange in an adult male

نویسندگان

  • Kunal Chaudhary
  • Ji-Young Shin
  • Georges Saab
  • Alan M. Luger
چکیده

Henoch-Schonlein purpura (HSP) frequently occurs in children under 15 years of age but is quite rare in adults. Most children who develop HSP nephritis completely recover from the illness, whereas up to 40% of adults have persistent hematuria and 10% develop chronic renal failure. Plasma exchange alone has been shown to be beneficial in children who have HSP nephritis. Adults have been treated using immunosuppressive drugs such as cyclophosphamide but effects are not certain. Here, we present a case of a 59-year-old white male who developed HSP nephritis while undergoing treatment with steroids. The patient developed acute renal failure with proteinuria and hematuria ∼2 weeks after being initially diagnosed with HSP by skin biopsy. Renal biopsy showed proliferative, exudative glomerulonephritis involving all 20 glomeruli; some with early crescent formation. Immunofluorescence staining showed 3+ IgA deposits in mesangium suggesting HSP-induced GN. The patient's serum creatinine rose to 2.5 mg/dl with ∼5 g of proteinuria by dipstick. Steroids were continued and the patient received plasma exchange treatments. Due to a very low leukocyte count, immunosuppressive agents were not given. Subsequently, renal function improved and the creatinine level came down to 1.3 mg/dl and proteinuria to <1 g/24 h. Since then, 1 year after this event, his serum creatinine has continued to stay at 1.2 mg/dl and he has trace proteinuria while taking a low-dose ACE inhibitor. This case illustrates the usefulness of plasma exchange in adult onset HSP nephritis, even without concomitant use of cytotoxic agents.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Henoch-Schonlein purpura with multiple symptoms in adult patient: a case report

Background: Henoch-Schonlein purpura is a common systemic vasculitis in childhood, usually characterized by skin, abdominal, and renal manifestations. Most patients are 4 to 7 years old and are more common in boys. The disease is very rare in adults with multiple symptoms. Case Report: A 20-year-old male patient with final diagnosis of Henoch-Schonlein disease with rare complications was admitt...

متن کامل

Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis

A 27-year-old man presented with a palpable purpuric skin rash and joint and abdominal pain in April 2010. He had acute kidney injury and his creatinine quickly deteriorated to 687 μmol/L, with associated nephrotic range proteinuria. Kidney biopsy showed crescentic Henoch-Schonlein nephritis. He was treated with intravenous cyclophosphamide and prednisolone despite which his renal function dete...

متن کامل

Itching Papules in a child; Scabies or Henoch Schonlein Purpura?

Introduction: Henoch schonlein purpura (HSP) is a self-limited systemic disease with multiorgan involvement. While cutaneous involvement may wary, presenting as itching papules is not a common manifestation. In this report we discuss a case of HSP which was presented solely with itching papules; mistaken for scabies. Case presentation: A 7 year old boy presented with itchy palpable papules with...

متن کامل

Henoch-Schonlein purpura in children from the eastern province of Saudi Arabia.

OBJECTIVE To evaluate the epidemiological and clinical profile of children with Henoch-Schonlein purpura (HSP) in eastern Saudi Arabia during a 15-year period. METHODS The medical records of children discharged with a diagnosis of HSP from King Fahad Hospital of the University, Al-Khobar, Saudi Arabia, between January 1996, and December 2010, were reviewed retrospectively. RESULTS Of 78 pat...

متن کامل

Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report.

In the current report, we describe a patient with moderate nephritis and severe skin Henoch Schönlein purpura (HSP) who has been treated with rituximab. Complete and sustained skin and renal remission resulted from the treatment. Thus, further studies are required to confirm the efficacy of rituximab as first-line treatment in HSP, and it might be an interesting new therapeutic option.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 1  شماره 

صفحات  -

تاریخ انتشار 2008